Close this search box.

Community Symposium Agenda

Community Symposium on the Molecular Basis of ME / CFS at Stanford University

Sponsored by OMF

Saturday, August 12, 2017

Registration begins 8 AM; Conference 9 AM – 5 PM; Reception 5PM – 6PM (all Pacific Time)


08:00 a.m. Registration
09:00 a.m. Welcome: Linda Tannenbaum, CEO, OMF
09:03 a.m. Symposium Logistics: Ashley Haugen, Event Organizer
09:05 a.m. Opening Remarks – Ronald W. Davis, PhD, Stanford University
09:10 a.m. Keynote Speech – Robert K. Naviaux, MD, PhD, University of California, San Diego
The metabolism of the cell danger response, healing, and ME / CFS
09:30 a.m. Chris Armstrong, University of Melbourne
ME, metabolism and I
09:50 a.m. Jonas Bergquist, MD, PhD, Uppsala University
In search of biomarkers revealing pathophysiology in a Swedish ME / CFS patient cohort

Coffee break

10:40 a.m. Maureen Hanson, PhD, Cornell University
Probing metabolism in ME / CFS
11:00 a.m. Neil McGregor, MDSc, PhD, University of Melbourne
Genome-wide analysis & metabolome changes in ME / CFS
11:20 a.m. Alan Light, PhD, University of Utah
Gene variants, mitochondria & autoimmunity in ME / CFS
11:40 a.m. Panel Discussion – Morning Speakers


01:30 p.m. Baldomero Olivera, PhD, Howard Hughes Medical Institute and University of Utah
A novel source of drugs: the biodiversity of oceans
01:50 p.m. Mario Capecchi, PhD, Nobel laureate, University of Utah
The role of microglia in neuropsychiatric disorders
02:10 p.m. Mark Davis, PhD, Howard Hughes Medical Institute and Stanford University
Is CFS/ME an autoimmune disease?

Coffee break

03:00 p.m. Alain Moreau, PhD, University of Montreal
New research strategies for decoding ME / CFS to improve diagnosis and treatment
03:20 p.m. Wenzhong Xiao, PhD, Massachusetts General Hospital and Harvard Medical School
Big data analysis of patient studies of ME / CFS
03:40 p.m. Ronald W. Davis, Stanford University
Establishing new mechanistic and diagnostic paradigms for ME / CFS
04:00 p.m. Panel Discussion – Afternoon Speakers
04:30 p.m.
Closing Remarks: Linda Tannenbaum, OMF, CEO
Ronald W. Davis, PhD


Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669